Polyclonal Antibodies Market - Historic Data (2019-2024), Global Trends 2025, Growth Forecasts 2037
Polyclonal Antibodies Market in 2025 is assessed at USD 1.73 billion. The global Market size was worth over USD 1.66 billion in 2024 and is poised to grow at a CAGR of around 5.4%, reaching USD 3.29 billion revenue by 2037. Asia Pacific is likely to collect USD 1.55 billion by 2037, driven by extensive use of polyclonal antibodies in IHC.
The market expansion is due to the projected need for therapeutic applications, as polyclonal antibodies find extensive use in therapeutic applications, notably in the development of antivenom and immunoglobulin therapies, which can help in preventing hemolytic disease in newborns while modifying inflammatory reactions.
According to a report, about 25% of newborns suffer from hemolytic disease of the newborns (HDN), which requires transfusion. Due to this, this industry is expected to witness a substantial growth rate in the forecasted years.
In addition, adopting polyclonal antibodies is particularly important in cases where the multifaceted nature of diseases necessitates a comprehensive immune response. For instance, in antivenom therapy, polyclonal antibodies are harnessed to neutralize the venom components of various snake species effectively.
